chr3-189958001-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_018192.4(P3H2):c.2038C>T(p.Arg680Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,611,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
P3H2
NM_018192.4 stop_gained
NM_018192.4 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 2.95
Genes affected
P3H2 (HGNC:19317): (prolyl 3-hydroxylase 2) This gene encodes a member of the prolyl 3-hydroxylase subfamily of 2-oxo-glutarate-dependent dioxygenases. These enzymes play a critical role in collagen chain assembly, stability and cross-linking by catalyzing post-translational 3-hydroxylation of proline residues. Mutations in this gene are associated with nonsyndromic severe myopia with cataract and vitreoretinal degeneration, and downregulation of this gene may play a role in breast cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0418 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P3H2 | NM_018192.4 | c.2038C>T | p.Arg680Ter | stop_gained | 15/15 | ENST00000319332.10 | NP_060662.2 | |
P3H2 | NM_001134418.2 | c.1495C>T | p.Arg499Ter | stop_gained | 15/15 | NP_001127890.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P3H2 | ENST00000319332.10 | c.2038C>T | p.Arg680Ter | stop_gained | 15/15 | 1 | NM_018192.4 | ENSP00000316881 | P1 | |
P3H2 | ENST00000427335.6 | c.1495C>T | p.Arg499Ter | stop_gained | 15/15 | 1 | ENSP00000408947 | |||
P3H2 | ENST00000490940.1 | n.168C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151914Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
151914
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250470Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135494
GnomAD3 exomes
AF:
AC:
7
AN:
250470
Hom.:
AF XY:
AC XY:
3
AN XY:
135494
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1459124Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 10AN XY: 726110
GnomAD4 exome
AF:
AC:
18
AN:
1459124
Hom.:
Cov.:
29
AF XY:
AC XY:
10
AN XY:
726110
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151914Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74174
GnomAD4 genome
AF:
AC:
2
AN:
151914
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74174
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
P3H2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 15, 2023 | The P3H2 c.2038C>T variant is predicted to result in premature protein termination (p.Arg680*). To our knowledge, this variant has not been reported in the literature. While other nonsense and frameshift variants in P3H2 have been reported in individuals with myopia and/or cataracts (Guo et al. 2014. PubMed ID: 24172257; Khan et al. 2019. PubMed ID: 30608193), none have been reported downstream of this variant. Additionally, this variant is located in the terminal exon and therefore the transcript is not expected to undergo nonsense mediated decay. This variant is reported in 0.016% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-189675790-G-A). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 08, 2022 | This sequence change creates a premature translational stop signal (p.Arg680*) in the P3H2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 29 amino acid(s) of the P3H2 protein. This variant is present in population databases (rs751877902, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with P3H2-related conditions. ClinVar contains an entry for this variant (Variation ID: 844528). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
D;D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at